Ottawa – Health Canada has authorized the use of the Moderna SPIKEVAX™ Covid-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older. Health Canada received Moderna’s submission for its new Covid-19 vaccine on June 29, 2023. After a thorough, independent review of the evidence, Health Canada has determined that the vaccine meets the Department’s stringent safety, …